Top executives for the 190-hospital system will be eligible to earn performance awards based on achieving specific targets, weighted as:
- 80% for achieving certain EBITDA targets
- 20% for achieving certain quality metrics in three categories:
- Healthcare-associated infections and sepsis (30%)
- Complication and mortality (30%)
- Care experience (40%)
If targets are met, CEO Sam Hazen will receive 175% of base salary. This is up from 170% of base salary in 2024. Mike Marks, executive vice president and CFO, and Jon Foster, executive vice president and COO, will receive 125% of base salary.
Executives in the program can earn 25% to 200% of the EBITDA-weighted award based on performance, with 100% awarded for meeting the target. For quality metrics, they receive 0% to 200%, depending on results, with full payout at target. If EBITDA falls below 90% of target, no quality bonus is paid.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
